The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Inhalation Anesthesia Market Projected To Become By 2030 Based On Its 2026 Valuation?
The inhalation anesthesia market size has shown strong growth recently. It is projected to increase from $1.64 billion in 2025 to $1.78 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.6%. This historical expansion can be attributed to an upsurge in surgical procedures, increased investments by hospitals, technological advancements in anesthesia equipment, a growing emphasis on patient safety, and the development of healthcare infrastructure.
The inhalation anesthesia market size is anticipated to experience substantial growth in the forthcoming years. It is projected to expand to $2.51 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.0%. This expansion during the forecast period can be attributed to the uptake of AI-assisted anesthesia, increasing demand for sustainable anesthetic agents, the incorporation of IoT in operating rooms, a rise in outpatient surgeries, and the advancement of smart anesthesia delivery systems. Prominent trends expected in this period include heightened patient safety protocols, sophisticated anesthesia delivery systems, support for minimally invasive surgery, real-time anesthesia monitoring, and environmentally conscious anesthetic agents.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7198&type=smp
Which Market Drivers Are Supporting The Expansion Of The Inhalation Anesthesia Market?
The increasing geriatric population is anticipated to propel the growth of the inhalation anesthesia market during the forecast period. This rising elderly demographic is boosting the inhalation anesthesia market, as these individuals are highly susceptible to degenerative and chronic illnesses, leading to an increase in surgical procedures and therapies. Moreover, the growing geriatric population, which is more vulnerable to ailments such as cardiovascular, neurological, respiratory, and degenerative disorders, is further stimulating market expansion. It is often challenging to administer anesthesia via an intravenous route to geriatric patients due to issues like punctured blood vessels and difficulties with patient compliance. For instance, in July 2024, according to the UK Parliament’s House of Commons Library, a UK-based government administration, in 2022, there were 12.7 million people aged 65 or older in the UK. This figure is projected to rise to 22.1 million by 2072, accounting for 27% of the population. Therefore, the increasing geriatric population is expected to boost demand for inhalation anesthesia throughout the forecast period.
What Segment Groups Are Identified Within The Inhalation Anesthesia Market?
The inhalation anesthesia market covered in this report is segmented –
1) By Product: Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide
2) By Application: Induction, Maintenance
3) By End User: Hospitals, Ambulatory Surgical Centers
Which Companies Hold Significant Positions In The Inhalation Anesthesia Market?
Major companies operating in the inhalation anesthesia market are AbbVie Inc., Baxter International Inc., Sandoz AG, Piramal Enterprises Limited, Fresenius SE & Co KGaA, Hikma Pharmaceuticals PLC, Jiangsu Hengrui Medicine Co Ltd, Lunan Pharmaceutical Group Co Ltd, Troikaa Pharmaceuticals Ltd, Dechra Pharmaceuticals PLC, Aspen Pharmacare Holdings Limited, Maruishi Pharmaceutical Co Ltd, Nikko Chemicals (Japan), GlaxoSmithKline PLC, Boehringer Ingelheim International GmbH, Halocarbon Products Corporation, Abbott Laboratories, Baxter Healthcare (distinct manufacturing division) , Fresenius Kabi AG, Sedana Medical AB
Read the full inhalation anesthesia market report here:
https://www.thebusinessresearchcompany.com/report/inhalation-anesthesia-global-market-report
How Is The Inhalation Anesthesia Market Distributed Across Key Geographic Regions?
North America was the largest region in the inhalation anesthesia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inhalation anesthesia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Inhalation Anesthesia Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=7198&type=smp
Browse Through More Reports Similar to the Global Inhalation Anesthesia Market 2026, By The Business Research Company
Inhalation Anesthesia Market Report 2026
https://www.thebusinessresearchcompany.com/report/inhalation-anesthesia-global-market-report
Anesthesia And Respiratory Devices Market 2026
https://www.thebusinessresearchcompany.com/report/anesthesia-and-respiratory-devices-market
Anesthetics Market Report 2026
https://www.thebusinessresearchcompany.com/report/anesthetics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model